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Abstract
Hepatocellular carcinoma is a primary tumor of the liver, which usually develops in the setting of
chronic liver disease, particularly viral hepatitis. The diagnosis of hepatocellular carcinoma can be
difficult, and often requires the use of serum markers, one or more imaging modalities, and
histological confirmation. The authors describe a case of a 26-year-old woman with hepatocellular
carcinoma and multiple pulmonary metastases. She presented with hepatomegaly and sporadic fever,
and had negative hepatitis serology, normal alkaline phosphatase, and a rising serum alpha-fetoprotein
level. The diagnosis was confirmed by histopathology, after percutaneous liver biopsy. Although the
patient was in good health condition and had few symptoms, there was no possibility of treatment
due to the extension of the liver tumor and the number of pulmonary metastases.
Introduction
Hepatocellular carcinoma (HCC) is the main primary
hepatic tumor and one of the most common cancers
worldwide [1]. It is usually seen at the sixth and seventh
decades of life. Men are affected three times as often as
women, and blacks are affected twice as often as whites
[2]. The main risk factors associated with HCC are
hepatitis C virus (HCV) or hepatitis B virus (HBV)
infection and alcoholic cirrhosis; chronic hepatitis B is
the most frequent cause [3]. Some cases are also associated
with exposure to environmental carcinogens such as
aflatoxin [2]. Intra-hepatic recurrence is more frequent
but pulmonary metastasis is the chief site of extrahepatic
spread, followed by regional and distant lymph nodes,
musculoskeletal system, adrenal glands [4], kidneys and
bone marrow [3]. HCC has a dismal overall prognosis,
with more than 90% of affected individuals dying of the
disease [4]. Several methods of treatment for HCC are
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Multiple modalities are available to treat HCC, including
chemotherapy, liver resection, liver transplantation, and
ablative therapies such as radiofrequency ablation, trans-
arterial embolization and percutaneous ethanol injection
[5,6]. The suitable treatment depends on the stage of the
tumor at the moment of diagnosis. When pulmonary
metastases are present, surgical resection can still be an
option in some cases. We report a case of HCC with
pulmonary metastases and no possibility of surgical
treatment.
Case presentation
A 26-year-old female Brazilian Caucasian patient was
admitted to the hospital presenting with a one-month
history of right-sided pleuritic chest pain, nausea, two
episodes of hemoptysis and fever. There was no history of
weight loss during this period. Physical examination was
unremarkable, except for a hepatosplenomegaly and
diminished vesicular breath sounds over the right lung
base.
Laboratory evaluation revealed a red blood cell count of
3.89 × 10
6 cells/mm
3; hemoglobin, 10.5 g/dL; hematocrit,
31.5%; MCV, 81%; MCHC, 33.5%; platelet count,
298,000/mm
3, and normal white blood cell and differ-
ential count. Erythrocyte sedimentation rate was 107 mm,
and C-reactive protein levels were 13.97 mg/dL. Serum
AST and gamma-GT levels were 70 U/mL and 173 U/L,
respectively; ALT, alkaline phosphatase and bilirubin
levels were within the normal range. Hepatitis B and C
virus serology tests were negative, CEA was normal, and
alpha-fetoprotein level was above 300 UI/ml.
Chest radiograph demonstrated multiple variable sized
nodules in both lungs (Figure 1). Abdominal ultrasound
showed an enlarged liver with multiple hyperechoic
nodules. Chest computed tomography (CT) revealed
multiple well-defined nodules in a peripheral distribution
(Figure 2), and computed tomography of the abdomen
showed an enlarged liver with lobulated contours and an
extensive heterogeneous lesion (Figure 3).
Subsequently, liver and pleural biopsies were performed,
and confirmed the presence of a primary hepatocellular
carcinoma and multiple pulmonary metastases. There
were no signs of associated cirrhosis. Since the disease
was at a very advanced stage, she was offered palliative
chemotherapy. The patient had a poor response to
treatment and died three months later.
Discussion
Hepatocellular carcinoma is a common malignancy in
patients with chronic hepatitis. In fact, HBV and HCV
infection are the main etiologic factors for this neoplasm.
The tumor frequently metastasizes via the lymphatic
system, intrahepatic blood vessels or direct infiltration
[3]. The lung is the most common site for extrahepatic
spread, and its involvement is associated with a poor
prognosis [1]: during necropsy, 52% of patients with
primary liver carcinoma had evidences of pulmonary
metastases [7].
Figure 1. Chest X-ray showing multiple variable sized
nodules predominating in the inferior areas of the lungs.
Figure 2. Computed tomography of the lungs, with
pulmonary (A and B) and mediastinal (C and D) window
settings, showing well-defined nodules, in a peripheral
distribution.
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often unresectable [1]. However, pulmonary metasta-
sectomy can be indicated in cases where lesions are
smaller than 3 cm and limited to the lungs [4]. In order to
be eligible, the patient must be a good risk for surgical
intervention [1], and some factors including the number
and location of the lesions must also be considered [4].
Several imaging modalities are available for detection and
characterization of HCC and metastatic lesions. These
include ultrasonography, CT, magnetic resonance imaging
and positrons emission tomography. Contrast-enhanced
CT has high sensitivity (93%) and specificity (100%) for
detecting hepatic metastases [8].
Since our patient presented an extensive liver lesion and
multiple pulmonary nodules, surgical treatment was
discarded and she was started on palliative chemotherapy.
This case report describes an unusual presentation of HCC
in a young patient without chronic hepatitis. Although she
had few symptoms at the moment of diagnosis, her tumor
was already at an advanced stage, with multiple pulmon-
ary metastases.
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Figure 3. Computed tomography scans of the upper
abdomen showing hepatomegaly, with an extensive ill-defined
heterogeneous lesion in the hepatic parenchyma.
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